Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
Healthtrust
UBS
Dow
Chubb
AstraZeneca
Accenture
Merck

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021789

« Back to Dashboard

NDA 021789 describes METROGEL, which is a drug marketed by Galderma Labs Lp and Medicis and is included in three NDAs. It is available from five suppliers. There are two patents protecting this drug and two Paragraph IV challenges. Additional details are available on the METROGEL profile page.

The generic ingredient in METROGEL is metronidazole. There are eighteen drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 021789
Tradename:METROGEL
Applicant:Galderma Labs Lp
Ingredient:metronidazole
Patents:2
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 021789
Ingredient-typeNitroimidazoles
Medical Subject Heading (MeSH) Categories for 021789
Suppliers and Packaging for NDA: 021789
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METROGEL metronidazole GEL;TOPICAL 021789 NDA Galderma Laboratories, L.P. 0299-3820 N 0299-3820-00
METROGEL metronidazole GEL;TOPICAL 021789 NDA Galderma Laboratories, L.P. 0299-3820 N 0299-3820-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength1%
Approval Date:Jun 30, 2005TE:ABRLD:Yes
Patent:➤ Sign UpPatent Expiration:Feb 21, 2022Product Flag?YSubstance Flag?Delist Request?
Patented Use:ONCE A DAY TOPICAL TREATMENT OF THE INFLAMMATORY LESIONS OF ROSACEA
Patent:➤ Sign UpPatent Expiration:Feb 21, 2022Product Flag?YSubstance Flag?Delist Request?
Patented Use:ONCE A DAY TOPICAL TREATMENT OF THE INFLAMMATORY LESIONS OF ROSACEA

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Covington
Accenture
Teva
Chinese Patent Office
Mallinckrodt
Fish and Richardson
US Army
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.